Addleshaw Goddard and Hogan Lovells have advised on Clinigen's £135m initial public offering (IPO) on the Alternative Investment Market (AIM), thought to be the first float of a UK pharmaceutical company on the junior market for five years.
October 04, 2012 at 07:03 PM
1 minute read
The original version of this story was published on Legalweek
Addleshaw Goddard and Hogan Lovells have advised on Clinigen’s £135m initial public offering (IPO) on the Alternative Investment Market (AIM), thought to be the first float of a UK pharmaceutical company on the junior market for five years.
Addleshaws advised Clinigen, a UK-based pharmaceutical and service company which provides hospital-only drugs, with corporate partner Richard Lee and legal director Geoff Yates leading the firm’s team.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
